Key Insights

Highlights

Treatment Research

1 treatments under study, led by Mobile Phone Application Prorodinki

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05402046Not ApplicableUnknown

Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms

Showing all 1 trials

Research Network

Common Treatments

  • Mobile Phone Application Prorodinki1

Active Sponsors

  • Privolzhsky Research Medical University1
  • MelanomaPRO, Russia1

Top Investigators

Related Conditions

  • Melanoma In Situ1
  • Squamous Cell Carcinoma1
  • Nevus Pigmented1
  • Melanoma Skin1
  • Spot Pigmented1

Activity Timeline